Company / Operating Margin
Cartesian Therapeutics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-112.8%
FY2025
5-year range
-785.6% / -5.4%
FY2021-FY2025
Trend
+66.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 8 years, ranging from -30813.5% in FY2019 to -5.4% in FY2023.
Based on SEC 10-K filings.
-112.8% in FY2025 with a 5-year CAGR of +7087.9%.
Declined from -5.4% to -112.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +229.5pp
- 5-Year Change
- +7087.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 66.1% year-over-year.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -112.8% | +66.1% |
| FY2024 | -332.3% | -6054.1% |
| FY2023 | -5.4% | +98.4% |
| FY2022 | -342.4% | +56.4% |
| FY2021 | -785.6% | +89.1% |
| FY2020 | -7200.7% | +76.6% |
| FY2019 | -30813.5% | -5983.0% |
| FY2016 | -506.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026